These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17662773)

  • 41. Pharmacokinetics and pharmacodynamics of ximelagatran.
    Wolzt M; Sarich TS; Eriksson UG
    Semin Vasc Med; 2005 Aug; 5(3):245-53. PubMed ID: 16123911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombogenic evaluation of two mechanical heart valve prostheses using a new in-vitro test system.
    Kim CH; Steinseifer U; Schmitz-Rode T
    J Heart Valve Dis; 2009 Mar; 18(2):207-13. PubMed ID: 19455896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Failure of guideline-based anticoagulation in a patient with mitral prosthetic valve and recurrent thromboembolism.
    Mutlu H; Yerlioglu ME; Levy WK
    J Am Soc Echocardiogr; 2008 Mar; 21(3):296.e1-3. PubMed ID: 17681732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty.
    Dahl OE; Ogren M; Agnelli G; Eriksson BI; Cohen AT; Mouret P; Rosencher N; Bylock A; Panfilov S; Andersson M
    Pathophysiol Haemost Thromb; 2006; 35(6):428-34. PubMed ID: 17565235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of low and high dose melagatran and other antithrombotic drugs on platelet aggregation.
    Soslau G; Ando A; Floyd L; Hong T; Mathew L; Yen Y
    J Thromb Thrombolysis; 2008 Apr; 25(2):198-203. PubMed ID: 17710375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study.
    Douketis J; Cook D; Meade M; Guyatt G; Geerts W; Skrobik Y; Albert M; Granton J; Hébert P; Pagliarello G; Marshall J; Fowler R; Freitag A; Rabbat C; Anderson D; Zytaruk N; Heels-Ansdell D; Crowther M;
    Arch Intern Med; 2008 Sep; 168(16):1805-12. PubMed ID: 18779469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antithrombotic therapy after heart valve surgery--current evidence and future trends].
    Benesová M
    Cas Lek Cesk; 2011; 150(4-5):229-35. PubMed ID: 21634200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics, preliminary efficacy and safety of subcutaneous melagatran and oral ximelagatran : a multicentre study of thromboprophylaxis in elective abdominal surgery.
    Bergqvist D; Solhaug JH; Holmdahl L; Eriksson UG; Andersson M; Boberg B; Ogren M
    Clin Drug Investig; 2004; 24(3):127-36. PubMed ID: 17516699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.
    Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R
    Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticoagulant action of melagatran: a comparison between neonates and adults using calibrated automated thrombography (CAT).
    Cvirn G; Cimenti C; Kutschera J; Ferstl U; Wagner T; Muntean W; Jurgens G; Gallistl S; Koestenberger M
    Eur J Pediatr; 2007 May; 166(5):427-31. PubMed ID: 17047995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT.
    Cimenti C; Koestenberger M; Leschnik B; Haidl H; Muntean W
    Thromb Res; 2007; 119(3):361-7. PubMed ID: 16712904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful prosthetic mitral valve implantation in pigs.
    Gross DR; Dewanjee MK; Zhai P; Lanzo S; Wu SM
    ASAIO J; 1997; 43(5):M382-6. PubMed ID: 9360066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct imaging of bileaflet mechanical valve behavior in the tricuspid position.
    Ikeda K; Okazaki Y; Furukawa K; Ohtsubo S; Yunoki J; Natsuaki M; Itoh T
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):1014-9. PubMed ID: 16675254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin.
    Allou N; Piednoir P; Berroëta C; Provenchère S; Ibrahim H; Baron G; Montravers P; Iung B; Philip I; Ajzenberg N
    Heart; 2009 Oct; 95(20):1694-700. PubMed ID: 19482850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A step change in oral anticoagulation: lack of coagulation monitoring with ximelagatran.
    Carlsson SC; Schulman S
    Semin Vasc Med; 2005 Aug; 5(3):259-65. PubMed ID: 16123913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of melagatran, an inhibitor of thrombin, on fibrin deposits, haemodynamics, and platelet count in endotoxaemic pigs.
    Eriksson M; Saldeen T; Mattsson C; Larsson A
    Acta Anaesthesiol Scand; 2000 Jan; 44(1):24-31. PubMed ID: 10669267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects.
    Gustafsson D; Nyström J; Carlsson S; Bredberg U; Eriksson U; Gyzander E; Elg M; Antonsson T; Hoffmann K; Ungell A; Sörensen H; Någård S; Abrahamsson A; Bylund R
    Thromb Res; 2001 Feb; 101(3):171-81. PubMed ID: 11228340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
    Miller MM; Hipp R; Matsumura ME
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1167-9. PubMed ID: 18669529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful anticoagulation with dalteparin in a patient with mechanical heart valves.
    Maharaj S; Bayliff CD; Kovacs MJ
    Ann Pharmacother; 1999 Nov; 33(11):1188-91. PubMed ID: 10573318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.